Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 487

1.

Rational thromboprophylaxis in medical inpatients: not quite there yet.

Millar JA.

Med J Aust. 2008 Nov 3;189(9):504-6. Review.

PMID:
18976192
2.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
3.

Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.

Själander A, Jansson JH, Bergqvist D, Eriksson H, Carlberg B, Svensson P.

J Intern Med. 2008 Jan;263(1):52-60. Review.

5.

Enoxaparin for thromboprophylaxis after major trauma: potential cost implications.

Shorr AF, Ramage AS.

Crit Care Med. 2001 Sep;29(9):1659-65.

PMID:
11546959
6.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
7.
8.

Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings.

Hull RD.

Thromb Haemost. 2008 Mar;99(3):502-10. doi: 10.1160/TH07-08-0500. Review.

PMID:
18327398
9.

An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding.

Chiasson TC, Manns BJ, Stelfox HT.

PLoS Med. 2009 Jun 23;6(6):e1000098. doi: 10.1371/journal.pmed.1000098.

10.

Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.

Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA.

Ann Intern Med. 2007 Feb 20;146(4):278-88.

PMID:
17310052
11.

Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes?

Sharma A, Chatterjee S, Lichstein E, Mukherjee D.

J Thromb Haemost. 2012 Oct;10(10):2053-60. doi: 10.1111/j.1538-7836.2012.04874.x. Review.

12.

Economic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patients.

Pineo GF, Hull RD.

Clin Appl Thromb Hemost. 2009 Oct;15(5):489-500. doi: 10.1177/1076029609335910. Review.

PMID:
19520676
13.

Routine pharmacological venous thromboembolism prophylaxis in frail older hospitalised patients: where is the evidence?

Greig MF, Rochow SB, Crilly MA, Mangoni AA.

Age Ageing. 2013 Jul;42(4):428-34. doi: 10.1093/ageing/aft041. Review.

PMID:
23557678
14.

Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.

Farge D, Durant C, Villiers S, Long A, Mahr A, Marty M, Debourdeau P; Groupe Francophone Thrombose et Cancer (GFTC)..

Thromb Res. 2010 Apr;125 Suppl 2:S108-16. doi: 10.1016/S0049-3848(10)70027-X. Review.

PMID:
20433988
15.
16.
17.
18.

Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis.

Shorr AF, Jackson WL, Weiss BM, Moores LK.

Blood Coagul Fibrinolysis. 2007 Jun;18(4):309-16.

PMID:
17473570
19.

Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in Germany.

Schädlich PK, Kentsch M, Weber M, Kämmerer W, Brecht JG, Nadipelli V, Huppertz E.

Pharmacoeconomics. 2006;24(6):571-91.

PMID:
16761905
20.

Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis.

Bottaro FJ, Elizondo MC, Doti C, Bruetman JE, Perez Moreno PD, Bullorsky EO, Ceresetto JM.

Thromb Haemost. 2008 Jun;99(6):1104-11. doi: 10.1160/TH07-12-0759.

PMID:
18521515
Items per page

Supplemental Content

Support Center